Meet the Néphronté(e)s
PhD STUDENT
My name is Srishti, and I'm originally from India. Having earned my bachelor's and master's degrees in biotechnology, I'm now a doctoral candidate in Dr. Alexandra Cambier's laboratory at Sainte-Justine University Hospital Center in Canada. Passionate about immunology, I'm committed to understanding immune mechanisms to contribute to medical advancements, particularly in IgA nephropathy. From understanding the molecular mechanisms of immune responses to their impact on health, I strive to bridge the gap between theory and practice. I also explore new therapeutic avenues to revolutionize healthcare, with a vision of translating scientific discoveries into tangible benefits for society.
PhD STUDENT
My name is Lison Lachize, I am 22 years old, and I am currently completing a Master's degree internship in Dr. Alexandra Cambier's research team at the Sainte Justine University Hospital Research Center. French, I studied at Jean Monnet University in Saint-Étienne, where I earned my Bachelor's degree in Cellular Biology and Physiology in 2021. I then continued my studies in Lyon, pursuing a Master's degree in Molecular and Cellular Biology at Claude Bernard University Lyon 1. I am currently in my second and final year of my Master's program, specializing in Immunology, Immunopathology, and Immunotherapy. I work in the laboratory on TNF families in IgA nephropathy.
MASTER'S STUDENT
My name is Diane Leenhardt, and I am a 21-year-old French woman living in Canada. A graduate of Concordia University with a degree in Biology, specializing in Science, I lived in the United States for seven years, broadening my academic and cultural horizons. My experience there reinforced my passion for immunology, captivated by its crucial role in treating autoimmune diseases and preventing emerging health problems. Currently completing an internship at Sainte-Justine University Hospital Center, I am working on identifying biomarkers for Henoch-Schönlein Purpura. I hope to achieve conclusive results to contribute to advancing immunological research and improving medical solutions.
FOUNDER, MD-PhD
I completed my pediatric and pediatric nephrology training at the University of Paris in 2018. I then undertook my clinical fellowship in pediatric nephrology and kidney transplantation at Robert Debré Hospital in Paris. I obtained a PhD from the Doctoral School of Physiology, Pathophysiology and Therapeutics at Paris Diderot University. During my PhD, I conducted research on the fundamental role of CD89 in childhood IgA nephropathy at Bichat Hospital (Inflamex Inserm 1149 laboratory) under the supervision of Professor Renato Monteiro. I also worked on the role of collagen variants in IgA nephropathy with Professor Laurent Mesnard at Sorbonne University (UMR_S 1155 laboratory). My research focuses on the clinical specificities of IgA nephropathy in children, but also on the interest of immune biomarkers for the diagnosis and prognosis of the disease as well as the impact of genetic variants in the disease.
STUDENT
My name is Zoé, and I'm a third-year engineering student specializing in biology in France. I plan to specialize in Research and Development in my fourth year, aiming for a career in the medical field. I applied to Dr. Cambier's laboratory to experience research firsthand. Drawn to fundamental research, I appreciate the process of searching, testing hypotheses, finding results, and constantly iterating. In medical research, the essential goal is to advance our understanding and treatment of diseases. My internship on IgA nephropathy exemplifies this commitment to better understanding and treating conditions, particularly in children.
STUDENT
My name is Andréa, and I'm a sixth-year medical student in France, currently completing an internship in Dr. Cambier's laboratory to validate my Master's degree. Drawn to research to enrich my medical practice, I appreciate the constant reflection and the drive to understand phenomena and diseases. Pediatric research presents a unique challenge, requiring a different approach than that used in adult studies. IgA nephropathy illustrates this complexity, particularly regarding the still-evolving therapeutic framework. We are also exploring the pathophysiology in a fundamental way, highlighting its immunological aspects. In short, research offers a continuous and exciting challenge.
FR